Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Atrial Fibrillation to Prevent Stroke (Feasibility)
NCT02282098Phase 3Completed
- Sponsor
- Population Health Research Institute
- Start
- Nov 2014
- Primary completion
- Nov 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Active Colchicine with Placebo Colchicine (2 arms). Primary endpoints: Recruitment rates at 3 months and Drop-out rates at 3 months. Started Nov 2014; status: completed.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02282098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282098.